Literature DB >> 22098811

Surgical treatments for obesity.

Marion L Vetter1, Kristoffel R Dumon, Noel N Williams.   

Abstract

Bariatric surgery is currently the most effective and durable treatment option for extreme obesity. Restrictive procedures, such as AGB and SG, limit gastric capacity and, thus, food intake while leaving the gastrointestinal tract intact. Malabsorptive procedures, such as BPD, shorten the length of the intestine to decrease nutrient absorption. Combined procedures, such as RYGB, include restriction and gastrointestinal rearrangement. Procedures that bypass segments of the gut are associated with greater weight loss and greater improvements in comorbid conditions than is gastric banding. This may be due, in part, to the differential effects of gastrointestinal rearrangement on the secretion of orexigenic and anorexigenic gut peptides that regulate appetite, glucose homeostasis, and body weight. Bariatric surgery is generally associated with low rates of perioperative and postoperative morbidity and mortality, although rigorous comparative safety data are lacking. High-quality, long-term, randomized, controlled trials are needed to compare the efficacy, safety, and cost effectiveness of the various bariatric surgery procedures with each other, as well as with intensive nonsurgical weight loss interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098811     DOI: 10.1016/j.psc.2011.08.012

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  6 in total

1.  Surgical therapy for obesity.

Authors:  Noel N Williams
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-04

2.  Changes in Fasting and Prandial Gut and Adiposity Hormones Following Vertical Sleeve Gastrectomy or Roux-en-Y-Gastric Bypass: an 18-Month Prospective Study.

Authors:  Naji Alamuddin; Marion L Vetter; Rexford S Ahima; Louise Hesson; Scott Ritter; Alyssa Minnick; Lucy F Faulconbridge; Kelly C Allison; David B Sarwer; Jesse Chittams; Noel N Williams; Matthew R Hayes; James W Loughead; Ruben Gur; Thomas A Wadden
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

3.  Binge-eating disorder and the outcome of bariatric surgery in a prospective, observational study: Two-year results.

Authors:  Ariana M Chao; Thomas A Wadden; Lucy F Faulconbridge; David B Sarwer; Victoria L Webb; Jena A Shaw; J Graham Thomas; Christina M Hopkins; Zayna M Bakizada; Naji Alamuddin; Noel N Williams
Journal:  Obesity (Silver Spring)       Date:  2016-09-12       Impact factor: 5.002

4.  Changes in neural responsivity to highly palatable foods following roux-en-Y gastric bypass, sleeve gastrectomy, or weight stability: An fMRI study.

Authors:  Lucy F Faulconbridge; Kosha Ruparel; James Loughead; Kelly C Allison; Louise A Hesson; Anthony N Fabricatore; Amber Rochette; Scott Ritter; Ryan D Hopson; David B Sarwer; Noel N Williams; Allan Geliebter; Ruben C Gur; Thomas A Wadden
Journal:  Obesity (Silver Spring)       Date:  2016-05       Impact factor: 5.002

Review 5.  Managing obesity in primary care practice: a narrative review.

Authors:  Raymond Carvajal; Thomas A Wadden; Adam G Tsai; Katherine Peck; Caroline H Moran
Journal:  Ann N Y Acad Sci       Date:  2013-01-16       Impact factor: 5.691

Review 6.  Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes.

Authors:  Michelle E Kimple; Joshua C Neuman; Amelia K Linnemann; Patrick J Casey
Journal:  Exp Mol Med       Date:  2014-06-20       Impact factor: 8.718

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.